Sam is a professional trader and the lead stock market news writer at AskTraders. After starting his career in the forex market, Sam now focuses on gold and stocks with a preference for fundamental and macroeconomic analysis.
The share price of Kanabo Group (LON: KNB) is one of the biggest movers in London on Tuesday after the company said Materia's subsidiary, Materia Deutschland GmbH, has entered into an agreement with German medical cannabis manufacturer Eurox Pharma GmbH to distribute German-produced medical cannabis extracts.
In July, Kanabo announced the signing of a non-binding term sheet with Materia to acquire Materia's European businesses.
Kanabo said extracts are the “fastest growing format in Germany's medical cannabis market, exhibiting approximately +62% sequential quarterly growth at the beginning of this year.”
The agreement will add a new line of cannabis extracts products for Materia Deutschland's portfolio and help expand its distribution network across Germany, including new pharmacies that dispense extracts.
“This is a strategic step forward in our preparation for the market's increasing adoption of medical cannabis in the form of extracts. Our sales team is already trained and equipped to win new pharmacy customers with the addition of this new format,” said Nick Pateras, Managing Director, Europe at Materia.
Kanabo's shares have erased Monday's 2% decline and more, now up 10% so far during Tuesday's session, priced at 19.8p.
One of the most frequently asked questions we receive is, “what stocks are best to buy right now?” It's a wide-ranging question, but one that we have answered… Our AskTraders stock analysts regularly review the market and compile a list of which companies you should be adding to your portfolio, including short and longer-term positions. Here are the best stocks to buy right now
CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage . 75 % of retail investor accounts lose money when trading CFDs with this provider . You should consider whether you understand how CFDs work, and whether you can afford to take the high risk of losing your money .